CHI Advisors as of March 31, 2023
Portfolio Holdings for CHI Advisors
CHI Advisors holds 23 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prometheus Biosciences | 27.1 | $103M | 959k | 107.32 | |
| Pliant Therapeutics (PLRX) | 21.1 | $80M | 3.0M | 26.60 | |
| Vectivbio Hldg Ord Shs | 11.8 | $45M | 5.3M | 8.51 | |
| Cullinan Oncology (CGEM) | 9.0 | $34M | 3.3M | 10.23 | |
| Repare Therapeutics Ord (RPTX) | 7.8 | $30M | 3.0M | 9.84 | |
| Larimar Therapeutics (LRMR) | 3.3 | $12M | 2.7M | 4.53 | |
| Keros Therapeutics (KROS) | 2.9 | $11M | 261k | 42.70 | |
| Compass Therapeutics (CMPX) | 2.4 | $9.3M | 2.8M | 3.27 | |
| 2seventy Bio Common Stock | 2.3 | $8.7M | 855k | 10.20 | |
| Inozyme Pharma (INZY) | 2.0 | $7.7M | 1.3M | 5.73 | |
| Omega Therapeutics Common Stock (OMGAQ) | 1.7 | $6.4M | 1.1M | 6.03 | |
| Ikena Oncology (IKNA) | 1.5 | $5.7M | 1.7M | 3.45 | |
| Rallybio Corp (RLYB) | 1.1 | $4.3M | 761k | 5.71 | |
| Orchard Therapeutics Spon Ads New | 1.1 | $4.2M | 786k | 5.37 | |
| Chinook Therapeutics | 0.8 | $3.1M | 135k | 23.15 | |
| Precision Biosciences Ord | 0.7 | $2.6M | 3.5M | 0.75 | |
| Ovid Therapeutics (OVID) | 0.6 | $2.2M | 865k | 2.58 | |
| Kezar Life Sciences | 0.6 | $2.2M | 690k | 3.13 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 0.6 | $2.2M | 4.7M | 0.46 | |
| Corvus Pharmaceuticals (CRVS) | 0.6 | $2.1M | 2.3M | 0.91 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.5 | $2.0M | 767k | 2.67 | |
| Entrada Therapeutics (TRDA) | 0.2 | $817k | 56k | 14.50 | |
| Oncorus | 0.2 | $815k | 2.4M | 0.34 |
